Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Investing

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

587 Articles

Jon C. Ogg | Jan 13, 2012 at 7:51 AM EST

Merger-Arbs Cleaning Up in Inhibitex Buyout (INHX, BMY)

It is not that often that investors get to clean up in a merger arbitrage spread any longer. The buyout…

Paul Ausick | Jan 11, 2012 at 1:37 PM EST

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking…

Jon C. Ogg | Jan 10, 2012 at 3:47 PM EST

Achillion Pharma, Too Much of a Good Thing After 50% Gain? (ACHN, MRK, GILD, VRUS, BMY, INHX, VRTX)

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) has been on fire due to the rapid interest of hepatitis C treatments and the bidding of…

Jon C. Ogg | Jan 9, 2012 at 11:11 AM EST

Hepatitis-C to the Moon (BMY, INHX, ACHN, IDIX, VRTX)

You know how stocks sometimes react to news on peers… Today we are again seeing a run in the world…

Paul Ausick | Jan 9, 2012 at 8:06 AM EST

Inhibitex Stock up 150% in Pre-Market (BMY, INHX)

Bristol-Myers Squibb (NYSE: BMY) will pay $2.5 billion in cash (a 163% premium to Friday’s closing price) for hepatitis C…

Douglas A. McIntyre | Jan 9, 2012 at 6:47 AM EST

What’s Important in the Financial World (1/9/2012) Chevy Volt Revivial, M&A Monday

Deal makers were busy over the weekend. Strategic considerations were more the driver of activity than an improved economy, however.…

Douglas A. McIntyre | Jan 9, 2012 at 6:46 AM EST

Media Digest (1/9/2012) Reuters, WSJ, NYT, FT, Bloomberg

http://platform.twitter.com/widgets/hub.1324331373.html The U.S. may start legal proceedings against Swiss financial firm Wegelin & Co. based on beliefs that it helped…

Douglas A. McIntyre | Jan 8, 2012 at 5:07 PM EST

Bristol-Myers Squibb (BMY) To Buy Inhibitex (IHNX)

Bristol-Myers (NYSE: BMY) will buy Inhibitex (NASDAQ: IHNX) for $26 a share about 2.5x what the smaller company’s shares traded…

Douglas A. McIntyre | Nov 30, 2011 at 6:20 AM EST

Media Digest (11/30/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

The EU continues to work on its bailout fund and may ask the IMF for help. (Reuters) American Airlines parent…

Paul Ausick | Nov 21, 2011 at 1:47 PM EST

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1…

Paul Ausick | Oct 27, 2011 at 4:11 PM EDT

24/7 Closing Bell (F, NFLX, ITRI, V, RRC, PG, CL, XOM, OXY, ABX, JCI, BMY, MO, QUIK, KELYB, LDK, CENX, MDR, AVP)

The DJIA jumped above 12,000 in the opening minutes of trading this morning and had topped 12,200 by mid-afternoon. European…

Paul Ausick | Oct 20, 2011 at 10:58 AM EDT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…

Jon C. Ogg | Oct 19, 2011 at 10:18 AM EDT

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public. So what…

Jon C. Ogg | Oct 12, 2011 at 2:10 PM EDT

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…

Douglas A. McIntyre | Oct 6, 2011 at 7:27 PM EDT

America’s Recession-Proof Companies

With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there…

1 … 31 32 33 34 35 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Merger-Arbs Cleaning Up in Inhibitex Buyout (INHX, BMY)

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

Achillion Pharma, Too Much of a Good Thing After 50% Gain? (ACHN, MRK, GILD, VRUS, BMY, INHX, VRTX)

Hepatitis-C to the Moon (BMY, INHX, ACHN, IDIX, VRTX)

Inhibitex Stock up 150% in Pre-Market (BMY, INHX)

What’s Important in the Financial World (1/9/2012) Chevy Volt Revivial, M&A Monday

Media Digest (1/9/2012) Reuters, WSJ, NYT, FT, Bloomberg

Bristol-Myers Squibb (BMY) To Buy Inhibitex (IHNX)

Media Digest (11/30/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

24/7 Closing Bell (F, NFLX, ITRI, V, RRC, PG, CL, XOM, OXY, ABX, JCI, BMY, MO, QUIK, KELYB, LDK, CENX, MDR, AVP)

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

America’s Recession-Proof Companies

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

AI Infrastructure Scorecard: Which of These 3 Stocks Is Delivering on Triple-Digit Growth Promises

Are Big Banks Actually Buying XRP Right Now?

Dividend Safety Check: Energy Infrastructure Income ETFs (EMLP, ENFR)

The $30,000 Stock Sale That Subtly Pulled a 68-Year-Old's Social Security Into the Tax Torpedo

Suze Orman Says a $400,000 Rental Gain Can Trigger a $10,600 Medicare Bill and the Closing Date Is the Only Thing You Control

AI Infrastructure Scorecard: Which of These 3 Stocks Is Delivering on Triple-Digit Growth Promises

Are Big Banks Actually Buying XRP Right Now?

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Merger-Arbs Cleaning Up in Inhibitex Buyout (INHX, BMY)

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

Achillion Pharma, Too Much of a Good Thing After 50% Gain? (ACHN, MRK, GILD, VRUS, BMY, INHX, VRTX)

Hepatitis-C to the Moon (BMY, INHX, ACHN, IDIX, VRTX)

Inhibitex Stock up 150% in Pre-Market (BMY, INHX)

What’s Important in the Financial World (1/9/2012) Chevy Volt Revivial, M&A Monday

Media Digest (1/9/2012) Reuters, WSJ, NYT, FT, Bloomberg

Bristol-Myers Squibb (BMY) To Buy Inhibitex (IHNX)

Media Digest (11/30/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

24/7 Closing Bell (F, NFLX, ITRI, V, RRC, PG, CL, XOM, OXY, ABX, JCI, BMY, MO, QUIK, KELYB, LDK, CENX, MDR, AVP)

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

America’s Recession-Proof Companies

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

AI Infrastructure Scorecard: Which of These 3 Stocks Is Delivering on Triple-Digit Growth Promises

Are Big Banks Actually Buying XRP Right Now?

Dividend Safety Check: Energy Infrastructure Income ETFs (EMLP, ENFR)

Featured Reads

The $30,000 Stock Sale That Subtly Pulled a 68-Year-Old's Social Security Into the Tax Torpedo

Suze Orman Says a $400,000 Rental Gain Can Trigger a $10,600 Medicare Bill and the Closing Date Is the Only Thing You Control